Omeprazole Sulfone Market
Omeprazole Sulfone Market Analysis, By Formulation (Tablets, Powder Form) and By Region - Global Market Insights 2023 to 2033
Analysis of Omeprazole Sulfone Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Omeprazole Sulfone Market Outlook (2023 to 2033)
Based on the analysis by Fact.MR, the global omeprazole sulfone market is estimated to be valued at US$ 4,749.9 Million in 2023 and it is expected to grow at a CAGR of 4.5% to reach US$ 7,348.2 Million by the end of 2033.
The change in lifestyle of people, the increase in unhealthy eating habits, and the deprived sleep cycles are the major drivers of the omeprazole sulfone market. The increasing prevalence of one of the diseases named gastroesophageal reflux disease (GERD) is also responsible for the growth of the market.
There are several factors such as obesity, the use of certain medications without proper prescriptions, and medical conditions like pregnancy further increases the chances of having GERD, this creates the demand for certain medication to cure the disease, hence it triggers the omeprazole sulfone market.
| Report Attributes | Details |
|---|---|
|
Omeprazole Sulfone Market Size (2022A) |
US$ 4,547.1 Million |
|
Estimated Market Value (2023E) |
US$ 4,749.9 Million |
|
Forecasted Market Value (2033F) |
US$ 7,348.2 Million |
|
Global Market Growth Rate (2023-2033) |
4.5% CAGR |
|
US Market Growth Rate (2023-2033) |
3.5% CAGR |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Historical and Future Pathway Analysis for the Omeprazole Sulfone Market
Omeprazole sulfone is a drug that is more efficient than the normal omeprazole drug at reducing stomach acid. These drugs are Proton Pump Inhibitors (PPI) and are used to treat ulcers, gastroesophageal reflux diseases (GERD), and other diseases which are caused due to too much stomach acid.
In recent years, this omeprazole sulfone market has seen a very steep growth and it is expected that this trend will further continue in the upcoming years also.
- Short-term (2023-26): In recent times omeprazole sulfone is being sold over the counter (OTC) and the increasing popularity of OTC medications will have a positive impact on the market.
- Medium-term (2026-29): In the medium term, the market is positioned to witness steady market growth due aging population, gastro-related issues, and peptic ulcers among others. The market is expected to witness increased competition among manufacturers.
- Long-term (2029-33): In the longer term, overall research and development will increase. Most eminent players in the market are focused on finding unique solutions to penetrate the market. The increase in awareness among people about the benefits of using PPI drugs for the cure of reducing stomach acids will showcase a very steep growth for the market.
On the back of the aforementioned findings, the omeprazole sulfone market is anticipated to grow at a CAGR of 4.5% during the forecast period from 2023-2033, According to the Fact.MR, a market research and competitive intelligence provider.
Market Dynamics Outlook
“Rapid Increase of Gastroesophageal Reflux Diseases (GERD) Among People Has Led to an Increase in The Demand of Omeprazole Sulfone”
GERD is a medical condition or kind of disease in which the stomach acid increases a lot and goes to the esophagus, which results in a burning sensation in the heart, acid reflux, ulcers, and other medical conditions.
GERD nowadays is constantly increasing among people due to several factors like eating excessive junk food, which leads to obesity, no proper digestion of food, and not maintaining proper gut health. Pregnancy in women and the use of different kinds of medications without proper prescription are also responsible for different kinds of stomach or gastro-related issues. With the increase of GERD, the demand for the omeprazole sulfone market also increases rapidly.
In 2022, the global pharmaceutical market was valued at around US$ 1.4 trillion, and it is projected to experience continuous growth in the coming years. The increasing number of diseases like GERD in people is expected to boost the demand for omeprazole sulfone as more people want to get help from the diseases.
“Rising Demand for Over-the-Counter (OTC) Medications”
Omeprazole sulfone is also available as an OTC medication in many countries, and since it is responsible for giving relief from diseases like GERD, peptic ulcers, and medical conditions like an increase in stomach acids, people prefer to get the medication as an OTC medication itself rather than as a prescribed one to get quicker relief from their medical conditions.
OTC medications are becoming more popular and the demand is also rising because they are more affordable and convenient as compared to prescribed medications.
Hence, this contributes to the rising demand of the entire market for omeprazole sulfone.
“Side Effects Pose a Barrier to Market Expansion”
Like all other medications, omeprazole sulfone also has some side effects which pose a barrier to market expansion. The most common side effects include (Diarrhoea, Nausea, Vomiting, Headache, Constipation, and Abdominal pain).
The side effects are the biggest restraining factor for the market as it has been observed that most patients go through some sort of side effects after its consumption, but in most cases, they are very mild side effects and do eventually go away. This creates a sense of fear among patients about whether they should use the omeprazole sulfone or not and hence it creates a market barrier for its overall growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
What are the Factors Driving the Omeprazole Sulfone Market Demand Across North America?
The North American Market contains a high number of people who are currently suffering from GERD and other gastro-related issues. The high amount of junk food that is consumed in this entire region is responsible for people being obese in this region, and hence having diseases like GERD.
The high prevalence of GERD results in the growing market demand for omeprazole sulfone in the North American region.
- “During the period from 1999-2000 through 2017-2022 the obesity index in the North American region (especially United States), has increased from 30.5% to 41.9%. During the same time, the severe obesity index has also increased from 4.7% to 9.2%. The increase in the number of obese people results in diseases related to gastro like GERD which ultimately drive the market of omeprazole sulfone.”
- “The US Omeprazole Sulfone Market is expected to grow at a CAGR of 3.5% to reach US$ 1,405.71 Million by the end of 2033.”
Why China’s Omeprazole Sulfone Market is Growing?
China’s robust economy and well-established pharmaceutical industry contribute to the growing demand in the market. There are several factors responsible for this growth in the Chinese market.
- The increasing number of elderly people in China is very much responsible for this growth of the omeprazole sulfone market. Elderly people are more likely to suffer from GERD and other gastro-related issues, hence, they would require the proper medications for that. So the overall market for omeprazole sulfone will grow substantially.
- The increasing healthcare cost in China pushes normal people to buy medications from their nearby local shops hence promoting OTC (over-the-counter) medications. This very much drives the market as it can be available as an OTC medication.
- The increase in the number of women in their workforce. Women generally are more prone to suffer from diseases related to gastro or GERD as compared to men, and also due to their pregnancy, they are more prone to suffer from diseases related to gastro. Omeprazole sulfone is one of the drugs known to help with such causes, that’s why the overall market is also increasing rapidly.
Category-wise Insights
Why are the Tablets so Much Popular in the Omeprazole Sulfone Market?
Tablets as we all know are the most common form of dosage of any medication. The tablet form of dosage dominates the entire omeprazole sulfone market because of its practicality and the number of other advantages that they provide.
The normal tablet form of omeprazole sulfone is very much affordable as compared to all those other forms of dosage in this market. Also, the ease of availability in the case of tablets is very much high in the entire market, which makes it easier for people to get the medication very easily at OTC. Tablets are easy to swallow and also offer a consistent release of the medication. People prefer the tablet form more as compared to all those other forms of dosage that’s why it is becoming so much popular.
However, for people who suffer difficulty in swallowing or people who require very high dosages of medication or require frequent dosages of medication, for them tablets won’t be the ideal solution. They would be requiring an injectable form of dosage of the medication or maybe a powdered or liquified form.
How Does Conducting Different Trials of The Formulations Help the Manufacturers in The Market?
The different manufacturers are heavily investing in research and development, and finding innovations. Conducting trials to make different formulations will eventually help the manufacturers to get access to a wide number of different potential customers for the omeprazole sulfone market.
The creation of different formulations of omeprazole sulfone through trials can help manufacturers to make products that are more efficient and have fewer side effects. This will drive the market for the manufacturers and people would have different choices of formulation to choose.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Prominent Players
The prominent players in the omeprazole sulfone market are CAYMAN CHEMICAL, Nobel, Shouguang Fukang Pharmaceutical Co., Ltd, AstraZeneca, Zhengda Tianqing, Osaikon Yuekang Pharmaceutical Group Co., Ltd, Shenyang Pharmaceutical University.
Most of the manufacturers in the omeprazole sulfone market focus on the continuous development of the product through innovation and investing heavily in research and development for the introduction of new products. The aim is to develop new products which may have better efficiency and more safety or lesser side effects.
Geographic expansion is also one of the major business moves which the eminent players are looking ahead. The geographical expansion helps the company a lot to increase its market share and also helps the people who require the supply.
Fact.MR has provided detailed information about the price points of key manufacturers of omeprazole sulfone positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Segmentation of Omeprazole Sulfone Industry Research
-
By Formulation :
- Tablets
- Powder form
-
By Region :
- North America
- Europe
- East Asia
- South Asia & Oceania
- Latin America
- Middle East & Africa
Table of Content
1. Market – Executive Summary 2. Market Overview 2.1. Market Definition and Introduction 2.2. Market Taxonomy/ Research Scope 3. Market Background and Foundation Data 3.1. Global Gross Domestic Product Projection 3.2. Global Consumption of By Age and Gender Statistics 3.3. Medicinal and Pharmaceutical Facts 3.4. History and Evolution of Market 3.5. Key Trends in Chemical Industry 3.6. Market Opportunity Assessment 3.6.1. Total Available Market (US$ million) 3.6.2. Serviceable Addressable Market (US$ million) 3.6.3. Serviceable Obtainable Market (US$ million) 3.7. Market Dynamics 3.7.1. Market Growth Drivers 3.7.2. Market Restraints 3.7.3. Market Opportunity 3.7.4. Market Trends 3.8. Market Scenario Forecast Under Optimistic, Likely and Conservative Market Conditions 3.9. Industry Value and Supply Chain Analysis 3.9.1. Value Added at Each Node of Supply Chain 3.9.2. Gross Profitability Margins (at Every Level) 3.9.3. List of Key Participants 3.9.3.1. Component Supplier 3.9.3.2. Manufacturers 3.9.3.3. Distributors / Traders /Retailers 3.9.3.4. End Users (Prominent) 3.10. Forecast and Macro–Economic Factors – Relevance and Impact 3.11. Investment Feasibility Analysis 4. Global Demand (Kilo Tons) Analysis and Forecast 4.1. Historical Market Volume (Kilo Tons) Analysis, 2018–2022 4.2. Current and Future Market Volume (Kilo Tons) Projections, 2023–2033 4.2.1. Y–o–Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market – Pricing Analysis 5.1. Product Type and Country–Level Pricing Analysis 5.2. Global Average Pricing Analysis Benchmark 5.3. Factors Influencing Pricing 6. Global Market Analysis and Forecast, By Dosage Formulation 6.1. Introduction / Key Findings 6.2. Historical Market Size (US$ million) and Volume (Kilo Tons) Analysis By Dosage Formulation, 2018–2022 6.3. Current and Future Market Size (US$ million) Analysis and Volume (Kilo Tons) Forecast By Dosage Formulation, 2023–2033 6.3.1. Tablet 6.3.2. Powdered 6.4. Market Attractiveness Analysis By Dosage Formulation 7. Global Market Analysis and Forecast, By Region 7.1. Introduction 7.2. Historical Market Size (US$ million) and Volume (Kilo Tons) Analysis By Region, 2018–2022 7.3. Current Market Size (US$ million) Analysis and Volume (Kilo Tons) Forecast By Region, 2023–2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia & Oceania 7.3.6. Middle East & Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis and Forecast 8.1. Introduction / Key Findings 8.2. Pricing Analysis 8.3. Historical Market Size (US$ million) and Volume (Kilo Tons) Trend Analysis By Market Taxonomy, 2018–2022 8.4. Market Size (US$ million) and Volume (Kilo Tons) Forecast By Market Taxonomy, 2023–2033 8.4.1. By Country 8.4.1.1. U.S. 8.4.1.2. Canada 8.4.2. By Dosage Formulation 8.5. Market Attractiveness Analysis 8.5.1. By Country 8.5.2. By Dosage Formulation 9. Latin America Market Analysis and Forecast 9.1. Introduction / Key Findings 9.2. Pricing Analysis 9.3. Historical Market Size (US$ million) and Volume (Kilo Tons) Trend Analysis By Market Taxonomy, 2018–2022 9.4. Market Size (US$ million) and Volume (Kilo Tons) Forecast By Market Taxonomy, 2023–2033 9.4.1. By Country 9.4.1.1. Brazil 9.4.1.2. Mexico 9.4.1.3. Argentina 9.4.1.4. Rest of Latin America 9.4.2. By Dosage Formulation 9.5. Market Attractiveness Analysis 9.5.1. By Country 9.5.2. By Dosage Formulation 10. Europe Market Analysis and Forecast 10.1. Introduction / Key Findings 10.2. Pricing Analysis 10.3. Historical Market Size (US$ million) and Volume (Kilo Tons) Trend Analysis By Market Taxonomy, 2018–2022 10.4. Market Size (US$ million) and Volume (Kilo Tons) Forecast By Market Taxonomy, 2023–2033 10.4.1. By Country 10.4.1.1. Germany 10.4.1.2. France 10.4.1.3. Italy 10.4.1.4. Spain 10.4.1.5. U.K. 10.4.1.6. BENELUX 10.4.1.7. Russia 10.4.1.8. Rest of Europe 10.4.2. By Dosage Formulation 10.5. Market Attractiveness Analysis 10.5.1. By Country 10.5.2. By Dosage Formulation 11. East Asia Market Analysis and Forecast 11.1. Introduction / Key Findings 11.2. Pricing Analysis 11.3. Historical Market Size (US$ million) and Volume (Kilo Tons) Trend Analysis By Market Taxonomy, 2018–2022 11.4. Market Size (US$ million) and Volume (Kilo Tons) Forecast By Market Taxonomy, 2023–2033 11.4.1. By Country 11.4.1.1. China 11.4.1.2. Japan 11.4.1.3. South Korea 11.4.2. By Dosage Formulation 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Dosage Formulation 12. South Asia & Oceania Market Analysis and Forecast 12.1. Introduction / Key Findings 12.2. Pricing Analysis 12.3. Historical Market Size (US$ million) and Volume (Kilo Tons) Trend Analysis By Market Taxonomy, 2018–2022 12.4. Market Size (US$ million) and Volume (Kilo Tons) Forecast By Market Taxonomy, 2023–2033 12.4.1. By Country 12.4.1.1. India 12.4.1.2. Thailand 12.4.1.3. Indonesia 12.4.1.4. Malaysia 12.4.1.5. Australia & New Zealand 12.4.1.6. Rest of South Asia & Oceania 12.4.2. By Dosage Formulation 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Dosage Formulation 13. Middle East & Africa Market Analysis and Forecast 13.1. Introduction / Key Findings 13.2. Pricing Analysis 13.3. Historical Market Size (US$ million) and Volume (Kilo Tons) Trend Analysis By Market Taxonomy, 2018–2022 13.4. Market Size (US$ million) and Volume (Kilo Tons) Forecast By Market Taxonomy, 2023–2033 13.4.1. By Country 13.4.1.1. GCC Countries 13.4.1.2. South Africa 13.4.1.3. Northern Africa 13.4.1.4. Turkiye 13.4.1.5. Rest of Middle East & Africa 13.4.2. By Dosage Formulation 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Dosage Formulation 14. Country–level Market Analysis and Forecast 14.1. Introduction / Key Findings 14.1.1. Market Value Proportion Analysis, By Key Countries 14.1.2. Global Vs. Country Growth Comparison 14.2. US Market Analysis 14.2.1. Value Proportion Analysis by Market Taxonomy 14.2.2. Volume (Kilo Tons) and Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.2.2.1. By Dosage Formulation 14.3. Canada Market Analysis 14.3.1. Value Proportion Analysis by Market Taxonomy 14.3.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.3.2.1. By Dosage Formulation 14.4. Brazil Market Analysis 14.4.1. Value Proportion Analysis by Market Taxonomy 14.4.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.4.2.1. By Dosage Formulation 14.5. Mexico Market Analysis 14.5.1. Value Proportion Analysis by Market Taxonomy 14.5.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.5.2.1. By Dosage Formulation 14.6. Argentina Market Analysis 14.6.1. Value Proportion Analysis by Market Taxonomy 14.6.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.6.2.1. By Dosage Formulation 14.7. Germany Market Analysis 14.7.1. Value Proportion Analysis by Market Taxonomy 14.7.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.7.2.1. By Dosage Formulation 14.8. France Market Analysis 14.8.1. Value Proportion Analysis by Market Taxonomy 14.8.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.8.2.1. By Dosage Formulation 14.9. Italy Market Analysis 14.9.1. Value Proportion Analysis by Market Taxonomy 14.9.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.9.2.1. By Dosage Formulation 14.10. Spain Market Analysis 14.10.1. Value Proportion Analysis by Market Taxonomy 14.10.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.10.2.1. By Dosage Formulation 14.11. BENELUX Market Analysis 14.11.1. Value Proportion Analysis by Market Taxonomy 14.11.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.11.2.1. By Dosage Formulation 14.12. Russia Market Analysis 14.12.1. Value Proportion Analysis by Market Taxonomy 14.12.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.12.2.1. By Dosage Formulation 14.13. U.K. Market Analysis 14.13.1. Value Proportion Analysis by Market Taxonomy 14.13.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.13.2.1. By Dosage Formulation 14.14. China Market Analysis 14.14.1. Value Proportion Analysis by Market Taxonomy 14.14.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.14.2.1. By Dosage Formulation 14.15. Japan Market Analysis 14.15.1. Value Proportion Analysis by Market Taxonomy 14.15.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.15.2.1. By Dosage Formulation 14.16. South Korea Market Analysis 14.16.1. Value Proportion Analysis by Market Taxonomy 14.16.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.16.2.1. By Dosage Formulation 14.17. India Market Analysis 14.17.1. Value Proportion Analysis by Market Taxonomy 14.17.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.17.2.1. By Dosage Formulation 14.18. GCC Countries Market Analysis 14.18.1. Value Proportion Analysis by Market Taxonomy 14.18.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.18.2.1. By Dosage Formulation 14.19. Türkiye Market Analysis 14.19.1. Value Proportion Analysis by Market Taxonomy 14.19.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.19.2.1. By Dosage Formulation 14.20. South Africa Market Analysis 14.20.1. Value Proportion Analysis by Market Taxonomy 14.20.2. Volume (Kilo Tons) and Value (US$ million) Analysis and Forecast by Market Taxonomy, 2018–2033 14.20.2.1. By Dosage Formulation 15. Market Structure Analysis 15.1. Market Analysis by Tier of Companies 15.2. Market Share Analysis of Top Players 15.3. Market Presence Analysis 16. Competition Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking of Products 16.3. Competition Deep Dive: 16.3.1. CAYMAN CHEMICAL 16.3.1.1. Overview 16.3.1.2. Product Portfolio 16.3.1.3. Key Financials 16.3.1.4. Sales Footprint 16.3.1.5. SWOT Analysis 16.3.1.6. Key Developments 16.3.1.7. Strategy Overview 16.3.2. Shouguang Fukang Pharmaceutical Co., Ltd 16.3.2.1. Overview 16.3.2.2. Product Portfolio 16.3.2.3. Key Financials 16.3.2.4. Sales Footprint 16.3.2.5. SWOT Analysis 16.3.2.6. Key Developments 16.3.2.7. Strategy Overview 16.3.3. AstraZeneca 16.3.3.1. Overview 16.3.3.2. Product Portfolio 16.3.3.3. Key Financials 16.3.3.4. Sales Footprint 16.3.3.5. SWOT Analysis 16.3.3.6. Key Developments 16.3.3.7. Strategy Overview 16.3.4. Zhengda Tianqing 16.3.4.1. Overview 16.3.4.2. Product Portfolio 16.3.4.3. Key Financials 16.3.4.4. Sales Footprint 16.3.4.5. SWOT Analysis 16.3.4.6. Key Developments 16.3.4.7. Strategy Overview 16.3.5. Osaikon Yuekang Pharmaceutical Group Co., Ltd 16.3.5.1. Overview 16.3.5.2. Product Portfolio 16.3.5.3. Key Financials 16.3.5.4. Sales Footprint 16.3.5.5. SWOT Analysis 16.3.5.6. Key Developments 16.3.5.7. Strategy Overview 16.3.6. Shenyang Pharmaceutical University 16.3.6.1. Overview 16.3.6.2. Product Portfolio 16.3.6.3. Key Financials 16.3.6.4. Sales Footprint 16.3.6.5. SWOT Analysis 16.3.6.6. Key Developments 16.3.6.7. Strategy Overview 17. Assumptions & Acronyms Used 18. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ million) by Region, 2018–2022
Table 2: Global Market Value (US$ million) and Forecast by Region, 2023–2033
Table 3: Global Market Volume (Kilo Tons) by Region, 2018–2022
Table 4: Global Market Volume (Kilo Tons) and Forecast by Region, 2023–2033
Table 5: Global Market Value (US$ million) By Dosage Formulation, 2018–2022
Table 6: Global Market Value (US$ million) and Forecast By Dosage Formulation, 2023–2033
Table 7: Global Market Volume (Kilo Tons) By Dosage Formulation, 2018–2022
Table 8: Global Market Volume (Kilo Tons) and Forecast By Dosage Formulation, 2023–2033
Table 9: North America Market Value (US$ million) by Country, 2018–2022
Table 10: North America Market Value (US$ million) and Forecast by Country, 2023–2033
Table 11: North America Market Volume (Kilo Tons) by Country, 2018–2022
Table 12: North America Market Volume (Kilo Tons) and Forecast by Country, 2023–2033
Table 13: North America Market Value (US$ million) By Dosage Formulation, 2018–2022
Table 14: North America Market Value (US$ million) and Forecast By Dosage Formulation, 2023–2033
Table 15: North America Market Volume (Kilo Tons) By Dosage Formulation, 2018–2022
Table 16: North America Market Volume (Kilo Tons) and Forecast By Dosage Formulation, 2023–2033
Table 17: Latin America Market Value (US$ million) by Country, 2018–2022
Table 18: Latin America Market Value (US$ million) and Forecast by Country, 2023–2033
Table 19: Latin America Market Volume (Kilo Tons) by Country, 2018–2022
Table 20: Latin America Market Volume (Kilo Tons) and Forecast by Country, 2023–2033
Table 21: Latin America Market Value (US$ million) By Dosage Formulation, 2018–2022
Table 22: Latin America Market Value (US$ million) and Forecast By Dosage Formulation, 2023–2033
Table 23: Latin America Market Volume (Kilo Tons) By Dosage Formulation, 2018–2022
Table 24: Latin America Market Volume (Kilo Tons) and Forecast By Dosage Formulation, 2023–2033
Table 25: Europe Market Value (US$ million) by Country, 2018–2022
Table 26: Europe Market Value (US$ million) and Forecast by Country, 2023–2033
Table 27: Europe Market Volume (Kilo Tons) by Country, 2018–2022
Table 28: Europe Market Volume (Kilo Tons) and Forecast by Country, 2023–2033
Table 29: Europe Market Value (US$ million) By Dosage Formulation, 2018–2022
Table 30: Europe Market Value (US$ million) and Forecast By Dosage Formulation, 2023–2033
Table 31: Europe Market Volume (Kilo Tons) By Dosage Formulation, 2018–2022
Table 32: Europe Market Volume (Kilo Tons) and Forecast By Dosage Formulation, 2023–2033
Table 33: East Asia Market Value (US$ million) by Country, 2018–2022
Table 34: East Asia Market Value (US$ million) and Forecast by Country, 2023–2033
Table 35: East Asia Market Volume (Kilo Tons) by Country, 2018–2022
Table 36: East Asia Market Volume (Kilo Tons) and Forecast by Country, 2023–2033
Table 37: East Asia Market Value (US$ million) By Dosage Formulation, 2018–2022
Table 38: East Asia Market Value (US$ million) and Forecast By Dosage Formulation, 2023–2033
Table 39: East Asia Market Volume (Kilo Tons) By Dosage Formulation, 2018–2022
Table 40: East Asia Market Volume (Kilo Tons) and Forecast By Dosage Formulation, 2023–2033
Table 41: South Asia & Oceania Market Value (US$ million) by Country, 2018–2022
Table 42: South Asia & Oceania Market Value (US$ million) and Forecast by Country, 2023–2033
Table 43: South Asia & Oceania Market Volume (Kilo Tons) by Country, 2018–2022
Table 44: South Asia & Oceania Market Volume (Kilo Tons) and Forecast by Country, 2023–2033
Table 45: South Asia & Oceania Market Value (US$ million) By Dosage Formulation, 2018–2022
Table 46: South Asia & Oceania Market Value (US$ million) and Forecast By Dosage Formulation, 2023–2033
Table 47: South Asia & Oceania Market Volume (Kilo Tons) By Dosage Formulation, 2018–2022
Table 48: South Asia & Oceania Market Volume (Kilo Tons) and Forecast By Dosage Formulation, 2023–2033
Table 49: MEA Market Value (US$ million) by Country, 2018–2022
Table 50: MEA Market Value (US$ million) and Forecast by Country, 2023–2033
Table 51: MEA Market Volume (Kilo Tons) by Country, 2018–2022
Table 52: MEA Market Volume (Kilo Tons) and Forecast by Country, 2023–2033
Table 53: MEA Market Value (US$ million) By Dosage Formulation, 2018–2022
Table 54: MEA Market Value (US$ million) and Forecast By Dosage Formulation, 2023–2033
Table 55: MEA Market Volume (Kilo Tons) By Dosage Formulation, 2018–2022
Table 56: MEA Market Volume (Kilo Tons) and Forecast By Dosage Formulation, 2023–2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ million) and Volume (Kilo Tons) Forecast, 2023–2033
Figure 2: Global Market Absolute $ Opportunity (US$ million), 2023–2033
Figure 3: Global Market Value (US$ million) and Volume (Kilo Tons) by Region, 2023 & 2033
Figure 4: Global Market Y–o–Y Growth Rate by Region, 2023–2033
Figure 5: Global Market Value (US$ million) and Volume (Kilo Tons) By Dosage Formulation, 2023 & 2033
Figure 6: Global Market Y–o–Y Growth Rate By Dosage Formulation, 2023–2033
Figure 7: North America Market Value (US$ million) and Volume (Kilo Tons) Forecast, 2023–2033
Figure 8: North America Market Absolute $ Opportunity (US$ million), 2023–2033
Figure 9: North America Market Value (US$ million) and Volume (Kilo Tons) by Country, 2023 & 2033
Figure 10: North America Market Y–o–Y Growth Rate by Country, 2023–2033
Figure 11: North America Market Value (US$ million) and Volume (Kilo Tons) By Dosage Formulation, 2023 & 2033
Figure 12: North America Market Y–o–Y Growth Rate By Dosage Formulation, 2023–2033
Figure 13: North America Market Attractiveness Analysis by Country, 2023–2033
Figure 14: North America Market Attractiveness Analysis By Dosage Formulation, 2023–2033
Figure 15: Latin America Market Value (US$ million) and Volume (Kilo Tons) Forecast, 2023–2033
Figure 16: Latin America Market Absolute $ Opportunity (US$ million), 2023–2033
Figure 17: Latin America Market Value (US$ million) and Volume (Kilo Tons) by Country, 2023 & 2033
Figure 18: Latin America Market Y–o–Y Growth Rate by Country, 2023–2033
Figure 19: Latin America Market Value (US$ million) and Volume (Kilo Tons) By Dosage Formulation, 2023 & 2033
Figure 20: Latin America Market Y–o–Y Growth Rate By Dosage Formulation, 2023–2033
Figure 21: Latin America Market Attractiveness Analysis by Country, 2023–2033
Figure 22: Latin America Market Attractiveness Analysis By Dosage Formulation, 2023–2033
Figure 23: Europe Market Value (US$ million) and Volume (Kilo Tons) Forecast, 2023–2033
Figure 24: Europe Market Absolute $ Opportunity (US$ million), 2023–2033
Figure 25: Europe Market Value (US$ million) and Volume (Kilo Tons) by Country, 2023 & 2033
Figure 26: Europe Market Y–o–Y Growth Rate by Country, 2023–2033
Figure 27: Europe Market Value (US$ million) and Volume (Kilo Tons) By Dosage Formulation, 2023 & 2033
Figure 28: Europe Market Y–o–Y Growth Rate By Dosage Formulation, 2023–2033
Figure 29: Europe Market Attractiveness Analysis by Country, 2023–2033
Figure 30: Europe Market Attractiveness Analysis By Dosage Formulation, 2023–2033
Figure 31: East Asia Market Value (US$ million) and Volume (Kilo Tons) Forecast, 2023–2033
Figure 32: East Asia Market Absolute $ Opportunity (US$ million), 2023–2033
Figure 33: East Asia Market Value (US$ million) and Volume (Kilo Tons) by Country, 2023 & 2033
Figure 34: East Asia Market Y–o–Y Growth Rate by Country, 2023–2033
Figure 35: East Asia Market Value (US$ million) and Volume (Kilo Tons) By Dosage Formulation, 2023 & 2033
Figure 36: East Asia Market Y–o–Y Growth Rate By Dosage Formulation, 2023–2033
Figure 37: East Asia Market Attractiveness Analysis by Country, 2023–2033
Figure 38: East Asia Market Attractiveness Analysis By Dosage Formulation, 2023–2033
Figure 39: South Asia & Oceania Market Value (US$ million) and Volume (Kilo Tons) Forecast, 2023–2033
Figure 40: South Asia & Oceania Market Absolute $ Opportunity (US$ million), 2023–2033
Figure 41: South Asia & Oceania Market Value (US$ million) and Volume (Kilo Tons) by Country, 2023 & 2033
Figure 42: South Asia & Oceania Market Y–o–Y Growth Rate by Country, 2023–2033
Figure 43: South Asia & Oceania Market Value (US$ million) and Volume (Kilo Tons) By Dosage Formulation, 2023 & 2033
Figure 44: South Asia & Oceania Market Y–o–Y Growth Rate By Dosage Formulation, 2023–2033
Figure 45: South Asia & Oceania Market Attractiveness Analysis by Country, 2023–2033
Figure 46: South Asia & Oceania Market Attractiveness Analysis By Dosage Formulation, 2023–2033
Figure 47: MEA Market Value (US$ million) and Volume (Kilo Tons) Forecast, 2023–2033
Figure 48: MEA Market Absolute $ Opportunity (US$ million), 2023–2033
Figure 49: MEA Market Value (US$ million) and Volume (Kilo Tons) by Country, 2023 & 2033
Figure 50: MEA Market Y–o–Y Growth Rate by Country, 2023–2033
Figure 51: MEA Market Value (US$ million) and Volume (Kilo Tons) By Dosage Formulation, 2023 & 2033
Figure 52: MEA Market Y–o–Y Growth Rate By Dosage Formulation, 2023–2033
Figure 53: MEA Market Attractiveness Analysis by Country, 2023–2033
Figure 54: MEA Market Attractiveness Analysis By Dosage Formulation, 2023–2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What was the Global Omeprazole Sulfone Market Size Reported by Fact.MR for 2022?
The global omeprazole sulfone market was valued at US$ 4,547.1 Million in 2022.
What are the Regions Included in the Omeprazole Sulfone Market Study?
The regions included in the omeprazole sulfone market study include North America, Latin America, Europe, East Asia, South Asia & Oceania, Middle East & Africa.
Who are the Major Players Operating in the Omeprazole Sulfone Market?
Prominent players in the market are CAYMAN CHEMICAL, Nobel, Shouguang Fukang Pharmaceutical Co., Ltd, AstraZeneca, Zhengda Tianqing, Osaikon Yuekang Pharmaceutical Group Co., Ltd, Shenyang Pharmaceutical University.
What is the Estimated Valuation of the Omeprazole Sulfone Market in 2033?
The market is expected to reach a valuation of US$ 7,348.2 Million in 2033.
At what CAGR did the omeprazole sulfone market exhibit over the last five years?
The historical growth rate of the omeprazole sulfone market was 4.0% from 2018-2022.
What is the estimated US market size at the end of the forecast period (2023-33)?
The US market is expected to reach a valuation of US$ 1,405.7 Million in 2033.
What is the estimated Chinese market size at the end of the forecast period (2023-33)?
The Chinese market is expected to reach a valuation of US$ 2,569.7 Million in 2033.
What is the expected CAGR percentage in the medical formulation of omeprazole sulfone at the end of the forecast period (2023-33)?
The CAGR in the medical formulation of omeprazole sulfone is expected to grow by 4.5% during the assessment period 2023-33.
Omeprazole Sulfone Market